Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial

STUDY QUESTION: Is oral dydrogesterone 30 mg daily non-inferior to 8% micronized vaginal progesterone (MVP) gel 90 mg daily for luteal phase support in IVF? SUMMARY ANSWER: Oral dydrogesterone demonstrated non-inferiority to MVP gel for the presence of fetal heartbeats at 12 weeks of gestation (non-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Reprod
Main Authors: Griesinger, Georg, Blockeel, Christophe, Sukhikh, Gennady T, Patki, Ameet, Dhorepatil, Bharati, Yang, Dong-Zi, Chen, Zi-Jiang, Kahler, Elke, Pexman-Fieth, Claire, Tournaye, Herman
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6238366/
https://ncbi.nlm.nih.gov/pubmed/30304457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/humrep/dey306
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados